McGinley Orthopedics, manufacturer of IntelliSense® HandHeld Robotics, seeks to raise $40 million through a Regulation A+ equity crowdfunding investment offering. The company’s flagship IntelliSense Drill Technology is designed to drastically limit complications during routine orthopedic surgeries requiring screw and pin placement.
In 2018, McGinley marked the milestone of 500 surgeries performed using the IntelliSense HandHeld Robotics system.
Regulation A+ is a relatively new exemption allowing private companies to raise funding from the general public under the JOBS Act. Unlike traditional investments in private companies, investors in a Regulation A+ offering do not need to be accredited.
Investors can help the company accelerate the growth of its current products that enable orthopedic surgeons to deliver a better standard of care.
McGinley also plans to use proceeds for further development of its intellectual property portfolio. It has amassed 71 patent families with 104 issued patents and 22 pending patents to date.
CEO Joseph C. McGinley, M.D., Ph.D. said, “With a fully integrated engineering team and in-house manufacturing, we can identify and then solve patient-outcome problems with new surgical technologies, concept to production.”
McGinley Orthopedics, manufacturer of IntelliSense® HandHeld Robotics, seeks to raise $40 million through a Regulation A+ equity crowdfunding investment offering. The company's flagship IntelliSense Drill Technology is designed to drastically limit complications during routine orthopedic surgeries requiring screw and pin placement.
In 2018,...
McGinley Orthopedics, manufacturer of IntelliSense® HandHeld Robotics, seeks to raise $40 million through a Regulation A+ equity crowdfunding investment offering. The company’s flagship IntelliSense Drill Technology is designed to drastically limit complications during routine orthopedic surgeries requiring screw and pin placement.
In 2018, McGinley marked the milestone of 500 surgeries performed using the IntelliSense HandHeld Robotics system.
Regulation A+ is a relatively new exemption allowing private companies to raise funding from the general public under the JOBS Act. Unlike traditional investments in private companies, investors in a Regulation A+ offering do not need to be accredited.
Investors can help the company accelerate the growth of its current products that enable orthopedic surgeons to deliver a better standard of care.
McGinley also plans to use proceeds for further development of its intellectual property portfolio. It has amassed 71 patent families with 104 issued patents and 22 pending patents to date.
CEO Joseph C. McGinley, M.D., Ph.D. said, “With a fully integrated engineering team and in-house manufacturing, we can identify and then solve patient-outcome problems with new surgical technologies, concept to production.”
Copy to clipboard 
